HK Stock Market Move | INNOCARE(09969) rose more than 5% in early trading, and the self-developed VAV1 molecular glue degrading agent ICP-538 completed the first dose given to the subject.
China Resources Pharmaceutical Group Limited (09969) rose more than 5% in early trading, as of the time of publication, it increased by 3.41% to HK$12.42, with a turnover of HK$54.55 million.
INNOCARE (09969) surged over 5% in early trading, as of press time, it was up 3.41% to 12.42 Hong Kong dollars, with a turnover of 54.5545 million Hong Kong dollars.
On the news front, on March 16, INNOCARE announced that the company's independently developed VAV1 molecule glue degrader ICP-538 has completed dosing for the first subject. ICP-538 is a novel oral highly efficient, highly selective specific molecular glue degrader targeting VAV1 developed by INNOCARE. VAV1 is a key protein downstream of T cells and B cell receptors. Currently, there are no approved VAV1 targeting drugs on the market globally.
Related Articles
HK Stock Market Move | NVIDIA GTC leads the way "first stock of Token" XUNCE (03317) soared more than 5% in the morning, the company deeply seizes the value gap of AI data.
CMA LOGISTICS (01292) expects the net profit attributable to the parent company to be approximately 37 to 43 million yuan in 2025, a decrease of about 38.27% to 28.27% year-on-year.
MNSO (09896) spent $233,800 to repurchase 54,700 shares on March 16th.
HK Stock Market Move | NVIDIA GTC leads the way "first stock of Token" XUNCE (03317) soared more than 5% in the morning, the company deeply seizes the value gap of AI data.
CMA LOGISTICS (01292) expects the net profit attributable to the parent company to be approximately 37 to 43 million yuan in 2025, a decrease of about 38.27% to 28.27% year-on-year.
MNSO (09896) spent $233,800 to repurchase 54,700 shares on March 16th.
